PATH | VRL
Menu

Safety and Efficacy of an Attenuated Vaccine Against Severe Rotavirus Gastroenteritis

This study, published in the New England Journal of Medicine, evaluated the safety and efficacy of GSK’s rotavirus vaccine (Rotarix®), with a focus on determining risk of intussusception.

Author: Ruiz-Palacios G, Pérez-Schael I, Velázquez F, et al.

Published: 2006

» Visit web page (English)

(Located at content.nejm.org)

Citation: Ruiz-Palacios G, Pérez-Schael I, Velázquez F, et al. Safety and Efficacy of an Attenuated Vaccine Against Severe Rotavirus Gastroenteritis. New England Journal of Medicine. 2006;354(1):11-22.

» Download file (French)

244 KB PDF

Also known as: Sécurité et efficacité d’un vaccin atténué contre la gastro-entérite grave à rotavirus

» Download file (Russian)

253 KB PDF

Also known as: Безопасность и эффективность живой ослабленной антиротавирусной вакцины

» Download file (Spanish)

233 KB PDF

Also known as: Seguridad y eficacia de una vacuna atenuada frente a la gastroenteritis grave por rotavirus

Resource types: Peer-reviewed journal

Diseases/vaccines: Rotavirus

Topics: Vaccine safety and performance, Disease/vaccine specific information

Regions: Global